drugset
drugset / Trial / NCT02651623

Study to Evaluate The Effect Of Sertraline on the Cardiac Repolarization in Healthy Subjects

NCT02651623 ↗

Phase 1 Completed 54 enrolled Viatris Inc.
RandomizedCrossoverDouble-blindOther

Summary

The purpose of this study is to demonstrate a lack of effect of sertraline on QTc intervals relative to time-matched placebo in healthy subjects

Timeline

Start
2016-01
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Moxifloxacin Small molecule 400 mg —
Subject Sertraline Small molecule 200 mg —

Indications

No indication recorded.